# A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

> **NCT06296966** · PHASE2 · UNKNOWN · sponsor: **Vanda Pharmaceuticals** · enrollment: 40 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** VSJ-110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06296966
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-29
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06296966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06296966, "A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06296966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*